Attenuated Plaque at Nonculprit Lesions in Patients Enrolled in Intravascular Ultrasound Atherosclerosis Progression Trials

Attenuated Plaque at Nonculprit Lesions in Patients Enrolled in Intravascular Ultrasound Atherosclerosis Progression Trials Ozgur Bayturan, E. Murat Tuzcu, Stephen J. Nicholls, Craig Balog, Andrea Lavoie, Kiyoko Uno, Timothy D. Crowe, William A. Magyar, Kathy Wolski, Samir Kapadia, Steven E. Nissen,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JACC. Cardiovascular interventions 2009-07, Vol.2 (7), p.672-678
Hauptverfasser: Bayturan, Ozgur, MD, Tuzcu, E. Murat, MD, Nicholls, Stephen J., MBBS, PhD, Balog, Craig, BS, Lavoie, Andrea, MD, Uno, Kiyoko, MD, Crowe, Timothy D., BS, Magyar, William A., BS, Wolski, Kathy, MPH, Kapadia, Samir, MD, Nissen, Steven E., MD, Schoenhagen, Paul, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 678
container_issue 7
container_start_page 672
container_title JACC. Cardiovascular interventions
container_volume 2
creator Bayturan, Ozgur, MD
Tuzcu, E. Murat, MD
Nicholls, Stephen J., MBBS, PhD
Balog, Craig, BS
Lavoie, Andrea, MD
Uno, Kiyoko, MD
Crowe, Timothy D., BS
Magyar, William A., BS
Wolski, Kathy, MPH
Kapadia, Samir, MD
Nissen, Steven E., MD
Schoenhagen, Paul, MD
description Attenuated Plaque at Nonculprit Lesions in Patients Enrolled in Intravascular Ultrasound Atherosclerosis Progression Trials Ozgur Bayturan, E. Murat Tuzcu, Stephen J. Nicholls, Craig Balog, Andrea Lavoie, Kiyoko Uno, Timothy D. Crowe, William A. Magyar, Kathy Wolski, Samir Kapadia, Steven E. Nissen, Paul Schoenhagen This study was designed to evaluate the presence of attenuated plaque serially (baseline and 2-year follow-up) in 159 nonculprit coronary segments. Attenuated plaque was found in 17 of 159 patients (10.7%, 95% confidence interval: 6% to 17%). At baseline, there were no significant differences in clinical presentation and cardiovascular risk factors between patients with and without attenuation. During follow-up, attenuation remained stable, and no events occurred in the patients with attenuation. There was a relationship with mixed calcified lesions. These findings challenge the previous assumption that attenuated plaque is a finding limited to culprit lesions associated with acute clinical presentation.
doi_str_mv 10.1016/j.jcin.2009.05.007
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67519097</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1936879809003318</els_id><sourcerecordid>67519097</sourcerecordid><originalsourceid>FETCH-LOGICAL-c448t-ee84098cd8d1e72049a30cdfdb430b2a295a18ad9e036ddaf2b5c8f72d48baad3</originalsourceid><addsrcrecordid>eNp9kV9rFDEUxQdRbK1-AR8kT77N9CbzLwERllK1sOiC7XPIJHc0azapSaZQ_PJm2AWhD77kJuGcw72_W1VvKTQU6HC5b_ba-oYBiAb6BmB8Vp1TPg71OED_vNxFO9R8FPysepXSHmAAMbKX1RkVA-NUsPPqzyZn9IvKaMjOqd8LEpXJ1-D14u6jzWSLyQafiPVkp7JFnxO59jE4Vxzl88bnqB5UKnoVyZ0rrxQWb8gm_8QYknbraRPZxfAjYlrTyG20yqXX1Yu5FHxzqhfV3afr26sv9fbb55urzbbWXcdzjcg7EFwbbiiODDqhWtBmNlPXwsQUE72iXBmB0A7GqJlNvebzyEzHJ6VMe1G9P-bex1AGTFkebNLonPIYliSHsaeikClCdhTq0nKKOMuC4KDio6QgV-RyL1fkckUuoZcFeTG9O6Uv0wHNP8uJcRF8OAqwzPhgMcqkC0eNxkbUWZpg_5__8YldO-utVu4XPmLahyX6Qk9SmZgE-X1d-rpzEABtS3n7F540q20</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67519097</pqid></control><display><type>article</type><title>Attenuated Plaque at Nonculprit Lesions in Patients Enrolled in Intravascular Ultrasound Atherosclerosis Progression Trials</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Bayturan, Ozgur, MD ; Tuzcu, E. Murat, MD ; Nicholls, Stephen J., MBBS, PhD ; Balog, Craig, BS ; Lavoie, Andrea, MD ; Uno, Kiyoko, MD ; Crowe, Timothy D., BS ; Magyar, William A., BS ; Wolski, Kathy, MPH ; Kapadia, Samir, MD ; Nissen, Steven E., MD ; Schoenhagen, Paul, MD</creator><creatorcontrib>Bayturan, Ozgur, MD ; Tuzcu, E. Murat, MD ; Nicholls, Stephen J., MBBS, PhD ; Balog, Craig, BS ; Lavoie, Andrea, MD ; Uno, Kiyoko, MD ; Crowe, Timothy D., BS ; Magyar, William A., BS ; Wolski, Kathy, MPH ; Kapadia, Samir, MD ; Nissen, Steven E., MD ; Schoenhagen, Paul, MD</creatorcontrib><description>Attenuated Plaque at Nonculprit Lesions in Patients Enrolled in Intravascular Ultrasound Atherosclerosis Progression Trials Ozgur Bayturan, E. Murat Tuzcu, Stephen J. Nicholls, Craig Balog, Andrea Lavoie, Kiyoko Uno, Timothy D. Crowe, William A. Magyar, Kathy Wolski, Samir Kapadia, Steven E. Nissen, Paul Schoenhagen This study was designed to evaluate the presence of attenuated plaque serially (baseline and 2-year follow-up) in 159 nonculprit coronary segments. Attenuated plaque was found in 17 of 159 patients (10.7%, 95% confidence interval: 6% to 17%). At baseline, there were no significant differences in clinical presentation and cardiovascular risk factors between patients with and without attenuation. During follow-up, attenuation remained stable, and no events occurred in the patients with attenuation. There was a relationship with mixed calcified lesions. These findings challenge the previous assumption that attenuated plaque is a finding limited to culprit lesions associated with acute clinical presentation.</description><identifier>ISSN: 1936-8798</identifier><identifier>EISSN: 1876-7605</identifier><identifier>DOI: 10.1016/j.jcin.2009.05.007</identifier><identifier>PMID: 19628192</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aged ; Atherosclerosis - complications ; Atherosclerosis - diagnostic imaging ; Atherosclerosis - drug therapy ; Calcinosis - diagnostic imaging ; Cardiovascular ; coronary artery disease ; Disease Progression ; Female ; Fluorobenzenes - therapeutic use ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use ; imaging ; intravascular ultrasound ; Male ; Middle Aged ; Predictive Value of Tests ; Pyrimidines - therapeutic use ; Rosuvastatin Calcium ; Sulfonamides - therapeutic use ; Time Factors ; Treatment Outcome ; Ultrasonography, Interventional ; vulnerable plaque</subject><ispartof>JACC. Cardiovascular interventions, 2009-07, Vol.2 (7), p.672-678</ispartof><rights>American College of Cardiology Foundation</rights><rights>2009 American College of Cardiology Foundation</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c448t-ee84098cd8d1e72049a30cdfdb430b2a295a18ad9e036ddaf2b5c8f72d48baad3</citedby><cites>FETCH-LOGICAL-c448t-ee84098cd8d1e72049a30cdfdb430b2a295a18ad9e036ddaf2b5c8f72d48baad3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1936879809003318$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19628192$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bayturan, Ozgur, MD</creatorcontrib><creatorcontrib>Tuzcu, E. Murat, MD</creatorcontrib><creatorcontrib>Nicholls, Stephen J., MBBS, PhD</creatorcontrib><creatorcontrib>Balog, Craig, BS</creatorcontrib><creatorcontrib>Lavoie, Andrea, MD</creatorcontrib><creatorcontrib>Uno, Kiyoko, MD</creatorcontrib><creatorcontrib>Crowe, Timothy D., BS</creatorcontrib><creatorcontrib>Magyar, William A., BS</creatorcontrib><creatorcontrib>Wolski, Kathy, MPH</creatorcontrib><creatorcontrib>Kapadia, Samir, MD</creatorcontrib><creatorcontrib>Nissen, Steven E., MD</creatorcontrib><creatorcontrib>Schoenhagen, Paul, MD</creatorcontrib><title>Attenuated Plaque at Nonculprit Lesions in Patients Enrolled in Intravascular Ultrasound Atherosclerosis Progression Trials</title><title>JACC. Cardiovascular interventions</title><addtitle>JACC Cardiovasc Interv</addtitle><description>Attenuated Plaque at Nonculprit Lesions in Patients Enrolled in Intravascular Ultrasound Atherosclerosis Progression Trials Ozgur Bayturan, E. Murat Tuzcu, Stephen J. Nicholls, Craig Balog, Andrea Lavoie, Kiyoko Uno, Timothy D. Crowe, William A. Magyar, Kathy Wolski, Samir Kapadia, Steven E. Nissen, Paul Schoenhagen This study was designed to evaluate the presence of attenuated plaque serially (baseline and 2-year follow-up) in 159 nonculprit coronary segments. Attenuated plaque was found in 17 of 159 patients (10.7%, 95% confidence interval: 6% to 17%). At baseline, there were no significant differences in clinical presentation and cardiovascular risk factors between patients with and without attenuation. During follow-up, attenuation remained stable, and no events occurred in the patients with attenuation. There was a relationship with mixed calcified lesions. These findings challenge the previous assumption that attenuated plaque is a finding limited to culprit lesions associated with acute clinical presentation.</description><subject>Aged</subject><subject>Atherosclerosis - complications</subject><subject>Atherosclerosis - diagnostic imaging</subject><subject>Atherosclerosis - drug therapy</subject><subject>Calcinosis - diagnostic imaging</subject><subject>Cardiovascular</subject><subject>coronary artery disease</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Fluorobenzenes - therapeutic use</subject><subject>Humans</subject><subject>Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use</subject><subject>imaging</subject><subject>intravascular ultrasound</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Predictive Value of Tests</subject><subject>Pyrimidines - therapeutic use</subject><subject>Rosuvastatin Calcium</subject><subject>Sulfonamides - therapeutic use</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><subject>Ultrasonography, Interventional</subject><subject>vulnerable plaque</subject><issn>1936-8798</issn><issn>1876-7605</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kV9rFDEUxQdRbK1-AR8kT77N9CbzLwERllK1sOiC7XPIJHc0azapSaZQ_PJm2AWhD77kJuGcw72_W1VvKTQU6HC5b_ba-oYBiAb6BmB8Vp1TPg71OED_vNxFO9R8FPysepXSHmAAMbKX1RkVA-NUsPPqzyZn9IvKaMjOqd8LEpXJ1-D14u6jzWSLyQafiPVkp7JFnxO59jE4Vxzl88bnqB5UKnoVyZ0rrxQWb8gm_8QYknbraRPZxfAjYlrTyG20yqXX1Yu5FHxzqhfV3afr26sv9fbb55urzbbWXcdzjcg7EFwbbiiODDqhWtBmNlPXwsQUE72iXBmB0A7GqJlNvebzyEzHJ6VMe1G9P-bex1AGTFkebNLonPIYliSHsaeikClCdhTq0nKKOMuC4KDio6QgV-RyL1fkckUuoZcFeTG9O6Uv0wHNP8uJcRF8OAqwzPhgMcqkC0eNxkbUWZpg_5__8YldO-utVu4XPmLahyX6Qk9SmZgE-X1d-rpzEABtS3n7F540q20</recordid><startdate>20090701</startdate><enddate>20090701</enddate><creator>Bayturan, Ozgur, MD</creator><creator>Tuzcu, E. Murat, MD</creator><creator>Nicholls, Stephen J., MBBS, PhD</creator><creator>Balog, Craig, BS</creator><creator>Lavoie, Andrea, MD</creator><creator>Uno, Kiyoko, MD</creator><creator>Crowe, Timothy D., BS</creator><creator>Magyar, William A., BS</creator><creator>Wolski, Kathy, MPH</creator><creator>Kapadia, Samir, MD</creator><creator>Nissen, Steven E., MD</creator><creator>Schoenhagen, Paul, MD</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20090701</creationdate><title>Attenuated Plaque at Nonculprit Lesions in Patients Enrolled in Intravascular Ultrasound Atherosclerosis Progression Trials</title><author>Bayturan, Ozgur, MD ; Tuzcu, E. Murat, MD ; Nicholls, Stephen J., MBBS, PhD ; Balog, Craig, BS ; Lavoie, Andrea, MD ; Uno, Kiyoko, MD ; Crowe, Timothy D., BS ; Magyar, William A., BS ; Wolski, Kathy, MPH ; Kapadia, Samir, MD ; Nissen, Steven E., MD ; Schoenhagen, Paul, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c448t-ee84098cd8d1e72049a30cdfdb430b2a295a18ad9e036ddaf2b5c8f72d48baad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Aged</topic><topic>Atherosclerosis - complications</topic><topic>Atherosclerosis - diagnostic imaging</topic><topic>Atherosclerosis - drug therapy</topic><topic>Calcinosis - diagnostic imaging</topic><topic>Cardiovascular</topic><topic>coronary artery disease</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Fluorobenzenes - therapeutic use</topic><topic>Humans</topic><topic>Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use</topic><topic>imaging</topic><topic>intravascular ultrasound</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Predictive Value of Tests</topic><topic>Pyrimidines - therapeutic use</topic><topic>Rosuvastatin Calcium</topic><topic>Sulfonamides - therapeutic use</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><topic>Ultrasonography, Interventional</topic><topic>vulnerable plaque</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bayturan, Ozgur, MD</creatorcontrib><creatorcontrib>Tuzcu, E. Murat, MD</creatorcontrib><creatorcontrib>Nicholls, Stephen J., MBBS, PhD</creatorcontrib><creatorcontrib>Balog, Craig, BS</creatorcontrib><creatorcontrib>Lavoie, Andrea, MD</creatorcontrib><creatorcontrib>Uno, Kiyoko, MD</creatorcontrib><creatorcontrib>Crowe, Timothy D., BS</creatorcontrib><creatorcontrib>Magyar, William A., BS</creatorcontrib><creatorcontrib>Wolski, Kathy, MPH</creatorcontrib><creatorcontrib>Kapadia, Samir, MD</creatorcontrib><creatorcontrib>Nissen, Steven E., MD</creatorcontrib><creatorcontrib>Schoenhagen, Paul, MD</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>JACC. Cardiovascular interventions</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bayturan, Ozgur, MD</au><au>Tuzcu, E. Murat, MD</au><au>Nicholls, Stephen J., MBBS, PhD</au><au>Balog, Craig, BS</au><au>Lavoie, Andrea, MD</au><au>Uno, Kiyoko, MD</au><au>Crowe, Timothy D., BS</au><au>Magyar, William A., BS</au><au>Wolski, Kathy, MPH</au><au>Kapadia, Samir, MD</au><au>Nissen, Steven E., MD</au><au>Schoenhagen, Paul, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Attenuated Plaque at Nonculprit Lesions in Patients Enrolled in Intravascular Ultrasound Atherosclerosis Progression Trials</atitle><jtitle>JACC. Cardiovascular interventions</jtitle><addtitle>JACC Cardiovasc Interv</addtitle><date>2009-07-01</date><risdate>2009</risdate><volume>2</volume><issue>7</issue><spage>672</spage><epage>678</epage><pages>672-678</pages><issn>1936-8798</issn><eissn>1876-7605</eissn><abstract>Attenuated Plaque at Nonculprit Lesions in Patients Enrolled in Intravascular Ultrasound Atherosclerosis Progression Trials Ozgur Bayturan, E. Murat Tuzcu, Stephen J. Nicholls, Craig Balog, Andrea Lavoie, Kiyoko Uno, Timothy D. Crowe, William A. Magyar, Kathy Wolski, Samir Kapadia, Steven E. Nissen, Paul Schoenhagen This study was designed to evaluate the presence of attenuated plaque serially (baseline and 2-year follow-up) in 159 nonculprit coronary segments. Attenuated plaque was found in 17 of 159 patients (10.7%, 95% confidence interval: 6% to 17%). At baseline, there were no significant differences in clinical presentation and cardiovascular risk factors between patients with and without attenuation. During follow-up, attenuation remained stable, and no events occurred in the patients with attenuation. There was a relationship with mixed calcified lesions. These findings challenge the previous assumption that attenuated plaque is a finding limited to culprit lesions associated with acute clinical presentation.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>19628192</pmid><doi>10.1016/j.jcin.2009.05.007</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1936-8798
ispartof JACC. Cardiovascular interventions, 2009-07, Vol.2 (7), p.672-678
issn 1936-8798
1876-7605
language eng
recordid cdi_proquest_miscellaneous_67519097
source MEDLINE; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Aged
Atherosclerosis - complications
Atherosclerosis - diagnostic imaging
Atherosclerosis - drug therapy
Calcinosis - diagnostic imaging
Cardiovascular
coronary artery disease
Disease Progression
Female
Fluorobenzenes - therapeutic use
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
imaging
intravascular ultrasound
Male
Middle Aged
Predictive Value of Tests
Pyrimidines - therapeutic use
Rosuvastatin Calcium
Sulfonamides - therapeutic use
Time Factors
Treatment Outcome
Ultrasonography, Interventional
vulnerable plaque
title Attenuated Plaque at Nonculprit Lesions in Patients Enrolled in Intravascular Ultrasound Atherosclerosis Progression Trials
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T22%3A18%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Attenuated%20Plaque%20at%20Nonculprit%20Lesions%20in%20Patients%20Enrolled%20in%20Intravascular%20Ultrasound%20Atherosclerosis%20Progression%20Trials&rft.jtitle=JACC.%20Cardiovascular%20interventions&rft.au=Bayturan,%20Ozgur,%20MD&rft.date=2009-07-01&rft.volume=2&rft.issue=7&rft.spage=672&rft.epage=678&rft.pages=672-678&rft.issn=1936-8798&rft.eissn=1876-7605&rft_id=info:doi/10.1016/j.jcin.2009.05.007&rft_dat=%3Cproquest_cross%3E67519097%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67519097&rft_id=info:pmid/19628192&rft_els_id=S1936879809003318&rfr_iscdi=true